Strata Critical Medical, Inc.
NASDAQ:SRTAAirlines, Airports & Air Services
-$0.03 today
- Market cap
- $443.03M
- Beta
- 2.20
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.60
Volume 0.99M
Average 0.91M
SRTA Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Strata Critical Medical, Inc.NASDAQ: SRTA
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings remains negative
Q1 FY2026 retained earnings was -$143.4M, compared with -$190.39M a year earlier.
Context
- Retained earnings amounted to 43.8% of total assets at the end of Q1 FY2026, down 32.2 pp from a year earlier.
- Retained earnings grew in size in 2 of the last 3 fiscal years.
What to watch
Whether retained earnings keeps rising in the next quarterly balance sheet after a +24.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (145.55M) USD
- Year-over-year change
- +22.1%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (145.55M) | +22.1% |
| FY2024 | 2024-12-31 | (186.9M) | -17.0% |
| FY2023 | 2023-12-31 | (159.75M) | -54.1% |
| FY2022 | 2022-12-31 | (103.68M) | -35.7% |
| FY2021 | 2021-09-30 | (76.42M) | — |
Retained Earnings vs competitors
How SRTA compares with its peers on the latest reported figures
- Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +24.7% is the highest of 11, against a peer median of -3.7%.
- Retained earnings amounts to 43.8% of total assets for SRTA, versus a peer median of 42.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $552.83M USD | +1.1% | +3.9% | 143.7% | |
| Apr 2026 | $505.81M USD | -19.2% | -0.1% | 29.3% | |
| Feb 2026 | $201.16M USD | +9.1% | -2.9% | 55.4% | |
| Mar 2026 | $757K USD | -95.2% | -65.7% | 0.1% | |
| Mar 2026 | -$56.52M USD | +13.2% | — | 11.8% | |
| Mar 2026 | -$83.09M USD | -166.2% | — | 15.1% | |
SRTAStrata Critical Medical, Inc. | Mar 2026 | -$143.4M USD | +24.7% | — | 43.8% |
| Mar 2026 | -$226.01M USD | -8.4% | — | 29.8% | |
| Mar 2026 | -$448.32M USD | -48.9% | — | 99.8% | |
| Mar 2026 | -$699.43M USD | +9.1% | — | 91.6% | |
| Mar 2026 | -£856.59M GBP | +12.3% | — | 738.2% | |
| Peer median (excluding SRTA) | — | -3.7% | -1.5% | 42.6% | |
Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Sep 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.6M | 41.34M | 27.87M | 18.38M | 30.97M |
| Short-term Investments | 279.37M | 150.74M | 138.26M | 108.76M | 30.26M |
| Net Receivables | 5.55M | 10.88M | 21.01M | 21.59M | 39.96M |
| Inventory | 547K | 0 | 0 | 0 | 0 |
| Other Current Assets | 83K | 3.09M | 19.12M | 12.02M | 25M |
| Total Current Assets | 294.95M | 218.13M | 206.26M | 160.74M | 126.19M |
| Property, Plant & Equipment (Net) | 2.76M | 19.73M | 26.38M | 39.79M | 39.55M |
| Goodwill | 13.33M | 39.45M | 40.37M | 41.05M | 88.21M |
| Intangible Assets | 24.42M | 46.37M | 20.52M | 13.65M | 47.5M |
| Long-term Investments | 200K | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 232K | 1.36M | 1.4M | 1.44M | 24.02M |
| Total Non-current Assets | 40.94M | 106.9M | 88.68M | 95.93M | 199.28M |
| Total Assets | 335.88M | 325.03M | 294.94M | 256.68M | 325.47M |
| Account Payables | 6.37M | 16.54M | 0 | 0 | 19.14M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 6.85M | 6.66M | 0 |
| Other Current Liabilities | 5.98M | 6.71M | 23.86M | 12.77M | 0 |
| Total Current Liabilities | 12.78M | 26.61M | 35.49M | 22.73M | 19.79M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 451K | 185K | 348K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 31.45M | 8.96M | 4.96M | 5.81M | 23.6M |
| Total Non-current Liabilities | 31.73M | 23.93M | 25.15M | 12.01M | 26.61M |
| Total Liabilities | 44.51M | 50.54M | 60.64M | 34.74M | 46.4M |
| Common Stock | 7K | 7K | 7K | 7K | 7K |
| Retained Earnings | (76.42M) | (103.68M) | (159.75M) | (186.9M) | (145.55M) |
| Accumulated OCI | (898K) | 2.29M | 3.96M | 1.75M | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 291.37M | 274.49M | 234.3M | 221.94M | 279.07M |
| Total Debt | 716K | 18.33M | 24.53M | 9.32M | 3.31M |
| Net Debt | (1.88M) | (23.01M) | (3.35M) | (9.06M) | (27.66M) |
Strata Critical Medical, Inc.
NASDAQ:SRTA
Intrinsic Alpha fair value
Locked
Current Price
$4.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.